PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark
NCT ID: NCT05570279
Last Updated: 2024-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
314 participants
OBSERVATIONAL
2016-04-01
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Substudy one: A prospective biobank is collected with the purpose to identify predictive and prognostic markers for outcome.
Substudy two: MRI scans are performed to investigate the rate of pelvic insufficience fractures at one year post chemoradiotherapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer
NCT02646462
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
NCT05265169
Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells
NCT02113384
Pancreatic Cancer Recurrence in the Netherlands
NCT04605237
Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma
NCT05134961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Squamous cell carcinoma of the anus, and indication for curatively intended radiotherapy
* Written and oral consent
Exclusion Criteria
* Other malignant disease within 5 years except from basal cell carcinomas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Vejle Hospital
OTHER
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen-Lise Garm Spindler
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Herlev Hospital
Herlev, , Denmark
Vejle Hospital
Vejle, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFE-1523
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.